Volcano (NSDQ:VOLC) lowered its outlook for 2014 this morning, sending share prices down on Wall Street despite positive preliminary results for the 4th quarter.
MassDevice Earnings Roundup
St. Jude Medical beats guidance with Q4 prelims
AtriCure’s Q4 prelims send shares up
AngioDynamics swings to Q2 losses, but shares rise on earnings beat
AngioDynamics (NSDQ:ANGO) shares are up a tad today after the medical device company beat Wall Street’s expectations with its fiscal 2nd-quarter earnings.
Layoffs ahead as Urologix restructures
Biomet swings to Q2 black
Biomet posted fiscal 2nd-quarter profits today, reporting sales growth for its core hip and knee replacement products and gains across the board for its other medical device lines.
The news augurs well for other orthopedic device makers, as Biomet’s early quarterly reports are seen on Wall Street as bellwethers for the rest of the industry.
Analogic’s shares flop as equipment delays sink Q1
Elekta slides on H1 profit decline
Orthofix gets Nasdaq delisting warninga amid delayed earnings
Sirona closes fiscal year 2013 lower than expected
Sirona Dental Systems (NSDQ:SIRO) reported its FY 2013 4th quarter and its full year’s earnings, where it took a hit, according to Wall Street estimates.
Cyberonics soars on a strong Q2 results, record sales, boosted guidance
Cyberonics (NSDQ:CYBX) saw some significant interest from Wall Street today after posting record sales for its 2nd quarter and increasing its projections for the rest of the year.